Chiu Yi-Wen, Kopple Joel D, Mehrotra Rajnish
Division of Nephrology, Department of Internal Medicine, at Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Semin Nephrol. 2009 Jan;29(1):67-74. doi: 10.1016/j.semnephrol.2008.10.009.
Metabolic acidosis is an important cause of protein-energy wasting, commonly observed in chronic kidney disease (CKD). This wasting is, in part, a result of the imbalance between protein degradation and synthesis induced by metabolic acidosis. The increase in protein degradation seen with metabolic acidosis is largely secondary to increased activities of the adenosine triphosphate-dependent, ubiquitin-proteasome system and branched-chain ketoacid dehydrogenase. Studies consistently have shown increased protein degradation with lower serum bicarbonate levels and/or arterial pH; however, the evidence for the anti-anabolic effects of metabolic acidosis is less consistent. In contrast to these metabolic studies, many cross-sectional studies have shown a direct relationship between the severity of metabolic acidosis and the adequacy of nutritional status in CKD patients. Moreover, lower serum bicarbonate levels have been associated with better survival in some epidemiologic studies of patients undergoing maintenance hemodialysis. It is likely that these relationships are confounded by the direct association of dietary protein intakes with metabolic acidosis-controlling the survival data for measures of dietary protein intakes, malnutrition, and inflammation shows a rather steep increase in the risk of death with lower serum bicarbonate levels. Two randomized controlled studies have shown that correction of metabolic acidosis is associated with reduction in risk for hospitalization in chronic peritoneal dialysis patients; the studies in maintenance hemodialysis patients have been small and inconsistent. For now, metabolic studies and data from clinical trials lend support to the recommendations made by the Nutrition Workgroup of the Kidney Disease Outcomes Quality Initiative to maintain serum bicarbonate levels of 22 mEq/L or greater in all CKD patients. Limited data suggest that a higher serum bicarbonate level (around 24 mEq/L) may be even more beneficial, particularly in chronic peritoneal dialysis patients.
代谢性酸中毒是蛋白质 - 能量消耗的一个重要原因,常见于慢性肾脏病(CKD)。这种消耗部分是代谢性酸中毒引起的蛋白质降解与合成失衡的结果。代谢性酸中毒时蛋白质降解增加主要继发于三磷酸腺苷依赖的泛素 - 蛋白酶体系统和支链酮酸脱氢酶活性增加。研究一直表明,血清碳酸氢盐水平降低和/或动脉pH值降低时蛋白质降解增加;然而,代谢性酸中毒的抗合成代谢作用的证据并不那么一致。与这些代谢研究相反,许多横断面研究表明,CKD患者代谢性酸中毒的严重程度与营养状况是否充足之间存在直接关系。此外,在一些维持性血液透析患者的流行病学研究中,较低的血清碳酸氢盐水平与更好的生存率相关。这些关系很可能因膳食蛋白质摄入量与代谢性酸中毒的直接关联而混淆——控制膳食蛋白质摄入量、营养不良和炎症指标的生存数据显示,血清碳酸氢盐水平降低时死亡风险会急剧增加。两项随机对照研究表明,纠正代谢性酸中毒与慢性腹膜透析患者住院风险降低相关;维持性血液透析患者的研究规模较小且结果不一致。目前,代谢研究和临床试验数据支持肾脏疾病改善全球预后组织营养工作组提出的建议,即所有CKD患者的血清碳酸氢盐水平应维持在22 mEq/L或更高。有限的数据表明,更高的血清碳酸氢盐水平(约24 mEq/L)可能更有益,尤其是在慢性腹膜透析患者中。